PACS Group, Inc.

Earnings data Q1 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced the closing of its upsized underwritten public offering of 19,034,482 shares of its common stock, which includes (i) 2,777,778 shares of its common stock sold by the Company and (ii) 16,256,704 shares of common stock sold by certain selling stockholders, which includes the exercise in full by the underwriters of their 30-day option to purchase an additional 2,482,758 shares of common stock.

PACS Group, Inc. Announces Closing of Its Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares from the Selling Stockholders

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced the pricing of its upsized underwritten public offering of 16,551,724 shares of its common stock, which includes 2,777,778 shares of common stock sold by the Company and 13,773,946 shares of common stock sold by certain selling stockholders, at a public offering price of $36.25 per share, for total gross proceeds of approximately $101 million to the Company and approximately $499 million t.

PACS Group, Inc. Announces Pricing of Its Upsized Public Offering

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced the commencement of an underwritten public offering of 13,888,890 shares of its common stock, including 2,777,778 shares of common stock sold by the Company and 11,111,112 shares of common stock sold by certain selling stockholders. The selling stockholders also expect to grant the underwriters a 30-day option to purchase up to an additional 2,083,332 of shares of common stock. PACS will n.

PACS Group, Inc. Announces Proposed Offering of Its Common Stock

PACS Group is a hidden gem stock with strong growth potential in the skilled nursing and assisted living facility industry. The company has shown aggressive growth through acquisitions, and as SNF facilities mature, growth is likely to remain healthy. Despite limited analyst coverage, PACS stock has shown an uptrend and is expected to outperform index and healthcare sector returns in the next three to five years.

PACS Group: Under The Radar Healthcare Stock To Buy On Corrections

Cronos Group

IAMGOLD

Li Auto Inc.

Marathon Digital Holdings

MINISO Group Holding

Tempus AI Inc

The S&P 500 index touched highs of 5,670 in July. Over the last one month, the index movement has been volatile with a downward bias.

7 Growth Stocks to Buy on Corrections for 3X Returns by 2026

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. Reports Second Quarter 2024 Results.

PACS Group, Inc. Reports Second Quarter 2024 Results

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS Group” or the “Company”), today announced that it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. Management will host a call on Monday, August 12, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of the PACS Gr.

PACS Group to Announce Second Quarter 2024 Financial Results

Rapport Therapeutics Inc

Global markets are down as fears of an economic downturn triggered a near-term crisis. This is a reminder that corrections can come from most unexpected events.

3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns

Ibotta Inc

Loar Holdings Inc

Viking Holdings Ltd

ZEEKR Intelligent Technology Holding Ltd

The initial public offering (IPO) and the subsequent listing is one of the best times to buy new growth stocks. The markets are still in a phase of understanding the business potential and there is limited analyst coverage.

7 New Growth Stock Listings That Can Be Long-Term Wealth Creators

With the S&P 500 index trading near all-time highs, the initial public offering market has been robust. It's also not uncommon that quality IPO stocks remain under-the-radar for a while before surging higher as it catches analyst and investor attention.

3 Under-the-Radar IPO Stocks to Buy Before They Double

Abbott Labs

AstraZeneca

Intuitive Surgical

Merck

Pfizer

Tenet Healthcare

In my view, it's important for every individual to invest in equities. By just holding cash in a back account, there is bound to be loss of purchasing power when adjusted for inflation.

7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns

FLY-E Group Inc

The initial public offering activity in the U.S. hit a two-year high in the second quarter of 2024. During the quarter, there were 39 IPOs with $8.9 billion being raised.

3 New IPOs to Buy for 20-Bagger Returns by 2030

DraftKings

First Solar

Riot Blockchain

If we look at high-quality growth stocks, the revenue and EBITDA upside is not just for a year or two. Companies continue to grow at a CAGR of 20% to 30% in the long term.

7 Growth Stocks That Will Outperform the Markets Through 2028

If investors can spot high-quality new growth stocks early, the investment has the potential to deliver multibagger returns. While blue-chip stocks are a fortress for the portfolio, growth stocks offer millionaire-maker potential.

IPO Rockets: 3 New Growth Stocks to Buy for 10-Bagger Returns by 2030

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that subsidiaries of the Company have agreed to acquire the operations of 53 skilled nursing and assisted/independent living facilities across 8 western states. The facilities are currently operated by Prestige, a family company whose legacy of caring for seniors dates back to the 1940s. The operations are located in 8 states, including Oregon (21 facilities), Washington (19 facilities), I.

PACS Group Announces Pending Acquisition of Operations at 53 Facilities in Pacific Northwest, Real Estate Joint Venture on Majority of the Locations

For investors as well as traders, it's important to keep a close eye on initial public offerings. It presents an opportunity to consider exposure to new companies with an attractive business model and growth outlook.

3 Recent IPOs That Can Double in 3 Months

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that Evelyn Dilsaver has been appointed to serve as a member of its Board of Directors. “We're thrilled to have Evelyn join our board,” said Jason Murray, PACS Chairman and CEO. “She has great experience as an accounting and finance professional, not to mention her work on the boards of several other public companies. She'll bring added perspective and expertise to the board as we work to.

PACS Group Announces Appointment of Evelyn Dilsaver to Serve as Independent Board Director

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2024, reporting net income of $49.1 million, Adjusted EBITDA of $88.5 million and Adjusted EBITDAR of $152.5 million. Highlights: GAAP earnings per share for the quarter was $0.38, an increase of 31.0% over the prior year quarter. GAAP net i.

PACS Group, Inc. Reports First Quarter 2024 Results

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS Group” or the “Company”), today announced that it will release its first quarter 2024 financial results after market close on Monday, May 13, 2024. Management will host a call the following day, Tuesday, May 14, 2024, at 4:00 p.m. Eastern Time to discuss the financial results and related information. PACS Group invites current and prospective investors to listen to the call via webcast by going to the Investors section of t.

PACS Group to Announce First Quarter 2024 Financial Results

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (“PACS” or the “Company”) today announced the closing of its initial public offering of 21,428,572 shares of its common stock sold by the Company at a public offering price of $21.00 per share, for total gross proceeds of approximately $450 million, before deducting underwriting discounts and commissions and offering expenses. In addition, the underwriters have exercised their 30-day option to purchase an additional 3,214,284 shares of the Com.

PACS Group, Inc. Announces Closing of Its Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares from the Selling Stockholders

The company operates 208 facilities across 9 states, providing post-acute care to 20,000 patients on a daily basis.

PACS Group: A Healthy Debut For This Acute Care Provider

PACS Group shares rose 9.5% in their debut on the New York Stock Exchange on Thursday, valuing the healthcare firm at $4 billion.

Healthcare firm PACS Group's shares rise 9% in NYSE debut

FARMINGTON, Utah--(BUSINESS WIRE)--PACS Group, Inc. (“PACS” or the “Company”) today announced the pricing of its upsized initial public offering of 21,428,572 shares of its common stock being sold by the Company at a public offering price of $21.00 per share, for total gross proceeds of approximately $450 million, before deducting underwriting discounts and commissions and offering expenses. In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up t.

PACS Group, Inc. Announces Pricing of Its Upsized Initial Public Offering

Contineum Therapeutics Inc

Johnson & Johnson

Massimo Group

Rubrik Inc

UL Solutions Inc

Zhibao Technology Inc

Three IPOs priced in the first week of April, led by a sizable biotech. Two sizable listings are currently scheduled for the week ahead, although smaller issuers may join the calendar throughout the week.

U.S. IPO Weekly Recap: April IPO Market Gets A Boost From Large Launches And New Filings

PACS Group said it is seeking a valuation of as much as $3.25 billion in its U.S. initial public offering, the latest in a string of firms looking to take advantage of improving investor interest for new stocks.

News for PACS Group, Inc. Stock (PACS)